NCT05128201View on ClinicalTrials.gov

Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2026

Conditions
Oligometastatic Disease
Interventions
RADIATION

consolidative radiotherapy

local consolidative radiotherapy for all metastatic lesion (30-45Gy/3-8F)

Trial Locations (3)

330029

RECRUITING

Jiangxi Cancer Hospital, Nanchang

350011

RECRUITING

Fujian Cancer Hospital, Fuzhou

Unknown

RECRUITING

Ganzhou Cancer Hospital, Ganzhou

All Listed Sponsors
lead

Jiangxi Provincial Cancer Hospital

OTHER